RxDoctor Payments Data

David Ramski, MD

Orthopaedic Surgery · Bethlehem, PANPI 1528474061

Payments from drug & device makers

$5,041in general payments, 2019–2025

Across 61 payments — averaging $82.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3K
  • Synthes GmbH$1K
  • Johnson & Johnson$334
  • Medical Device Business Services, Inc.$305
  • Si-bone, Inc.$135
  • Integra Lifesciences Corporation$125
  • plus $387 from 5 others

What the payments were for

  • Grants$2505%
  • Travel & lodging$1,82036%
  • Food & beverage$2,72054%
  • Education$2505%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker35$2,545
Synthes GmbH2$1,210
Johnson & Johnson11$334
Medical Device Business Services, Inc.2$305
Si-bone, Inc.2$135
Integra Lifesciences Corporation1$125
Globus Medical2$113
KCI USA, Inc.1$88
Novus Surgical Solutions LLC2$82
Novus Surgical Consultants1$60
Heraeus Medical, LLC.2$44

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,041 in reported general payments places this provider in the 55th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$267,476
Medicare patients
505
Services billed
9,732

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enoxaparin Sodium28$3,501
Celecoxib48$609
Diclofenac Sodium21$396
Gabapentin46$285
Methylprednisolone37$255
Tramadol Hcl27$171
Methocarbamol30$163
Oxycodone Hcl28$133
Naproxen39$129
Cephalexin19$64
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$50
Meloxicam15$31

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Bethlehem

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →